NEW YORK (GenomeWeb News) – Aushon Biosystems has appointed Susan Vogt to be company CEO. Vogt has 30 years of experience in the life sciences, pharmaceutical, biotech, and clinical diagnostics markets, Aushon said.
She has held executive posts at SeraCare Life Sciences and at Millipore, and she currently is a non-executive director of TAP BioSystems.
Molecular biology developer Cernostics has named John Inadomi and Robert Murphy to serve as its scientific advisors.
They will help the company’s efforts to develop and commercialize a test that predicts the risk of esophageal cancer in patients with severe gastro-esophageal reflux disease and Barrett’s esophagus.
Inadomi is a professor of medicine and the division chief of gastroenterology at the University of Washington. Murphy is a professor of computational biology and director of the Ray and Stephanie Lane Center for Computational Biology at Carnegie Mellon University.
Precision Medicine said this week that Vicki Seyfert-Margolis has joined the company as chief of science and strategy.
Seyfert-Margolis formerly was a senior advisor on regulatory science and innovation at the US Food and Drug Administration, where she headed FDA’s regulatory science and personalized medicine initiative. She also previously was chief science officer at the Immune Tolerance Network.
Quest Diagnostics has appointed Jim Davis, former VP at three GE healthcare businesses, to be senior VP of diagnostic solutions, where he will take over for Kathy Ordonez, who plans to leave the company.
In the position, Davis will oversee diagnostic products, insurer services, clinical trials, healthcare IT, and employer solutions.
Davis previously was CEO of InSightec, and he held VP and GM roles at GE’s MRI, diagnostic imaging, and healthcare IT businesses.
Nayan Greg Parekh is leaving as CEO of Biocartis and is rejoining New Rhein Healthcare, which he helped found, GenomeWeb Daily News has learned. New Rhein Healthcare is an investor in Biocartis.
Rudi Pauwels will be CEO on an interim basis while the Swiss molecular diagnostics firm searches for a permanent replacement. Pauwels, who is also Biocartis' executive chairman, was its CEO before Parekh was named to that post at the end of 2011.
That time was marked by shift in focus from technology development to revenue generation.
Parekh also is leaving Biocartis' board where he served as an executive director since April 2011. Parekh's departure from Biocartis is effective immediately.
IntegenX this week announced the appointment of Robert Schueren as CEO.
Schueren most recently served as vice president and general manager of genomics for Agilent Technologies. Prior to joining Agilent in 2010, he was the global head of clinical biomarkers and operations and the deputy global head of molecular medicine labs at Genentech.
Schueren also served as senior director of development sciences and as director of companion diagnostics at Genentech. In addition, he previously was executive vice president and COO of Arcturus Bioscience; and has worked for Accumetrics, Biosite Diagnostics, and Gen-Probe (now Hologic).
Stevan Jovanovich, a founder and past president and CEO of IntegenX, will remain with the company as chief technology officer.
Applied BioCode said this week that it has appointed Michael Aye as vice president of molecular products.
Aye has previously been employed by Focus Diagnostics and Beckman Coulter. Prior to his industrial experience, he spent 10 years in academia focused on research in molecular genetics and microbiology.
Aye obtained a BS in microbiology in 1995 from California State University, Long Beach, and a PhD in biology in 2001 from the University of California, Irvine
University of Western Australia plant scientist Professor Harvey Millar has been awarded The Shull Award from the American Society of Plant Biologists.
Millar, who is deputy director at the ARC Centre of Excellence in Plant Energy Biology at UWA, won the accolade for his proteomics and metabolomics research into plant mitochondria, and oxidative stress in mitochondrial proteins.
Geneticist Catherine Peichel has received a John Simon Guggenheim Memorial Foundation Fellowship Award.
Peichel is a member of the Basic Sciences and Human Biology divisions at the Fred Hutchinson Cancer Research Center. She will use the $40,000 fellowship to take a nine month sabbatical to work in the lab of Walter Salzburger at the University of Basel. Her research efforts focus on the genetic basis of variation in body type and behavior between species, and she uses the threespine stickleback fish as her model.
Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in People In The News, a weekly roundup of industry comings and goings.